Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006875166> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2006875166 endingPage "30" @default.
- W2006875166 startingPage "23" @default.
- W2006875166 abstract "A selective, accurate and reproducible high-performance liquid chromatographic (HPLC) method for the separation of individual enantiomers of DRF 2725 [R(+)-DRF 2725 and S(-)-DRF 2725 or ragaglitazar] was obtained on a chiral HPLC column (Chiralpak). During method optimization, the separation of enantiomers of DRF 2725 was investigated to determine whether mobile phase composition, flow-rate and column temperature could be varied to yield the base line separation of the enantiomers. Following liquid-liquid extraction, separation of enantiomers of DRF 2725 and internal standard (I.S., desmethyl diazepam) was achieved using an amylose based chiral column (Chiralpak AD) with the mobile phase, n-hexane-propanol-ethanol-trifluoro acetic acid (TFA) in the ratio of 89.5:4:6:0.5 (v/v). Baseline separation of DRF 2725 enantiomers and I.S., free from endogenous interferences, was achieved in less than 25 min. The eluate was monitored using an UV detector set at 240 nm. Ratio of peak area of each enantiomer to I.S. was used for quantification of plasma samples. Nominal retention times of R(+)-DRF 2725, S(-)-DRF 2725 and I.S. were 15.8, 17.7 and 22.4 min, respectively. The standard curves for DRF 2725 enantiomers were linear (R(2) > 0.999) in the concentration range 0.3-50 microg/ml for each enantiomer. Absolute recovery, when compared to neat standards, was 70-85% for DRF 2725 enantiomers and 96% for I.S. from rat plasma. The lower limit of quantification (LLOQ) for each enantiomers of DRF 2725 was 0.3 microg/ml. The inter-day precisions were in the range of 1.71-4.60% and 3.77-5.91% for R(+)-DRF 2725, S(-)-DRF 2725, respectively. The intra-day precisions were in the range of 1.06-11.5% and 0.58-12.7% for R(+)-DRF 2725, S(-)-DRF 2725, respectively. Accuracy in the measurement of quality control (QC) samples was in the range 83.4-113% and 83.3-113% for R(+)-DRF 2725, S(-)-DRF 2725, respectively. Both enantiomers and I.S. were stable in the battery of stability studies viz., bench-top (up to 6 h), auto-sampler (up to 12 h) and freeze/thaw cycles (n = 3). Stability of DRF 2725 enantiomers was established for 15 days at -20 degrees C. The application of the assay to a pharmacokinetic study of ragaglitazar [S(-)-DRF 2725] in rats is described. It was unequivocally demonstrated that ragaglitazar does not undergo chiral inversion to its antipode in vivo in rat plasma." @default.
- W2006875166 created "2016-06-24" @default.
- W2006875166 creator A5025522255 @default.
- W2006875166 creator A5056647308 @default.
- W2006875166 creator A5056704911 @default.
- W2006875166 creator A5076878402 @default.
- W2006875166 creator A5083166265 @default.
- W2006875166 date "2004-09-01" @default.
- W2006875166 modified "2023-09-25" @default.
- W2006875166 title "Development and validation of a chiral liquid chromatographic method, based on Chiralpak® to quantify enantiomers of (±)-DRF 2725 in rat plasma: lack of inversion of ragaglitazar (S(−)-DRF 2725) to its antipode in plasma" @default.
- W2006875166 cites W2006998103 @default.
- W2006875166 cites W2046109662 @default.
- W2006875166 cites W2054762675 @default.
- W2006875166 cites W2060752803 @default.
- W2006875166 cites W2502670554 @default.
- W2006875166 doi "https://doi.org/10.1016/j.jchromb.2004.05.030" @default.
- W2006875166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15282089" @default.
- W2006875166 hasPublicationYear "2004" @default.
- W2006875166 type Work @default.
- W2006875166 sameAs 2006875166 @default.
- W2006875166 citedByCount "3" @default.
- W2006875166 countsByYear W20068751662014 @default.
- W2006875166 crossrefType "journal-article" @default.
- W2006875166 hasAuthorship W2006875166A5025522255 @default.
- W2006875166 hasAuthorship W2006875166A5056647308 @default.
- W2006875166 hasAuthorship W2006875166A5056704911 @default.
- W2006875166 hasAuthorship W2006875166A5076878402 @default.
- W2006875166 hasAuthorship W2006875166A5083166265 @default.
- W2006875166 hasConcept C179998833 @default.
- W2006875166 hasConcept C185592680 @default.
- W2006875166 hasConcept C43617362 @default.
- W2006875166 hasConcept C486523 @default.
- W2006875166 hasConcept C71240020 @default.
- W2006875166 hasConceptScore W2006875166C179998833 @default.
- W2006875166 hasConceptScore W2006875166C185592680 @default.
- W2006875166 hasConceptScore W2006875166C43617362 @default.
- W2006875166 hasConceptScore W2006875166C486523 @default.
- W2006875166 hasConceptScore W2006875166C71240020 @default.
- W2006875166 hasIssue "1" @default.
- W2006875166 hasLocation W20068751661 @default.
- W2006875166 hasLocation W20068751662 @default.
- W2006875166 hasOpenAccess W2006875166 @default.
- W2006875166 hasPrimaryLocation W20068751661 @default.
- W2006875166 hasRelatedWork W2021792606 @default.
- W2006875166 hasRelatedWork W2036826355 @default.
- W2006875166 hasRelatedWork W2038296721 @default.
- W2006875166 hasRelatedWork W2044621357 @default.
- W2006875166 hasRelatedWork W2044623385 @default.
- W2006875166 hasRelatedWork W2060483407 @default.
- W2006875166 hasRelatedWork W2079852636 @default.
- W2006875166 hasRelatedWork W2119552130 @default.
- W2006875166 hasRelatedWork W2166263961 @default.
- W2006875166 hasRelatedWork W2196125403 @default.
- W2006875166 hasVolume "809" @default.
- W2006875166 isParatext "false" @default.
- W2006875166 isRetracted "false" @default.
- W2006875166 magId "2006875166" @default.
- W2006875166 workType "article" @default.